Zonisamide is a 1,2-benzoxazole derivative featuring a sulfamoylmethyl substituent at the 3-position. It functions as a T-type calcium channel blocker, an antioxidant, and a central nervous system agent, and it is primarily recognized as an anticonvulsant used in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 68291-97-4
Amlexanox
pharmaceutical raw material
(−)-hyoscyamine sulfate dihydrate
pharmaceutical raw material
7-Methoxy-1-naphthaleneacetic acid
pharmaceutical raw material
Sulbactam
pharmaceutical raw material
3-Bromomethyl-1,2-benzisoxazole
pharmaceutical intermediate
2-(1,2-benzoxazol-3-yl)ethanoic acid
pharmaceutical intermediate
6-Amino-1,2-benzisoxazole
research compound
3-Amino-6-methoxy-1,2-benzisoxazole
research compound
1,2-benzoxazol-3-ylmethanesulfonamide
UBQNRHZMVUUOMG-UHFFFAOYSA-N
C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N